HEALEY ALS Platform Trial Regimen I Enrolment Completed – Topline Results For NUZ-001 Accelerated To Q2 CY2027

The HEALEY ALS Platform Trial Regimen I has completed enrolment, with topline results for NUZ-001 now scheduled for Q2 2027, advancing ALS research.

The Benefits Of Using A Recovery Percentile Tracker After Orthopedic Surgery

A new recovery percentile tracker for orthopedic patients aims to reduce post-surgery calls and improve patient reassurance through objective benchmarks.

Frederick Massage Therapist Creates Space For People To Put Themselves First Again

A massage therapist in Frederick has established a dedicated space encouraging individuals to prioritize their well-being and self-care.

Brayton Purcell LLP Highlights New Medical Report On Silicosis Risks

Brayton Purcell LLP emphasizes a new medical report warning of serious silicosis risks from artificial stone, questioning current safety controls.

The Future Of Gender-Affirming Voice Apps Is Here: Pocket Voice Lab

Pocket Voice Lab introduces a new app for gender-affirming voice training, offering real-time acoustic feedback for users without in-person therapy.

Deepening Collaboration In AI-Powered R&D Acceleration: Insilico Medicine And CMS Announce Additional Collaborations In CNS Diseases

Insilico Medicine and CMS announce new collaborations to accelerate research in CNS diseases using AI technology, strengthening their ongoing partnership.

Women’s Health Radar

A new digital health tool aims to identify early perimenopause symptoms in women 40-58, enabling timely care and reducing health and work disruptions.

INVESTOR ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity To Lead The GeneDx Class Action Lawsuit

Investors in GeneDx Holdings Corp. (WGS) with substantial losses may have the chance to join a class action lawsuit, according to recent PR Newswire release.

Retirement Care Planner

A new web-based tool is being tested to help adult children coordinate care and finances for aging parents, addressing rising costs and complex decisions.

Xeris Biopharma Surges In Global Coverage

Xeris Biopharma experiences a surge in worldwide media coverage, with 23 mentions in recent reports, signaling increased interest in its activities.